| Product Name | Thalidomide-d4 |
| Product Code | DA-T058-c |
| Chemical name | Thalidomide-d4 |
| Synonyms | 2-(2,6-Dioxopiperidin-3-yl)Isoindoline-1,3-Dione-4,5,6,7-d4; 4,5,6,7-Tetradeuterio-2-(2,6-Dioxopiperidin-3-yl)Isoindole-1,3-dione; (±)-Thalidomide D4 (Phenyl D4); 2-(2,6-Dioxo-3-Piperidinyl)-1H-Iso-Indole-1,3(2H)-Dione-d4; α-Phthalimidoglutarimide-d4; 3-Phthalimidoglutarimide-d4;Celgene-d4; Contergan-d4; Distaval-d4; K 17-d4; Kevadon-d4; Myrin-d4; N-(2,6-Dioxo-3-piperidyl)phthalimide-d4; |
| Impurity | NA |
| CAS Number | 1219177-18-0 |
| Alternate CAS # | NA |
| Molecular form | C13H6D4N2O4 |
| Appearance | Off-White to Beige Solid |
| Melting Point | NA |
| Mol. Weight | 262.25 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | pharmaceutical standards,intermediates,Fine Chemicals,stable isotopes |
| Boiling Point | NA |
| Applications | Labelled Thalidomide, which inhibits FGF-induced angiogenesis. Inhibits replication of human immunodeficiency virus type 1. Teratogenic sedative. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
